6 results on '"Tadeusz Hawrot"'
Search Results
2. Global synergistic actions to improve brain health for human development
- Author
-
Mayowa O. Owolabi, Matilde Leonardi, Claudio Bassetti, Joke Jaarsma, Tadeusz Hawrot, Akintomiwa I. Makanjuola, Rajinder K. Dhamija, Wuwei Feng, Volker Straub, Jennifer Camaradou, David W. Dodick, Rosita Sunna, Bindu Menon, Claire Wright, Chris Lynch, Antonella Santuccione Chadha, Maria Teresa Ferretti, Anna Dé, Coriene E. Catsman-Berrevoets, Muthoni Gichu, Cristina Tassorelli, David Oliver, Walter Paulus, Ramla K. Mohammed, Augustina Charway-Felli, Kevin Rostasy, Valery Feigin, Audrey Craven, Elizabeth Cunningham, Orla Galvin, Alexandra Heumber Perry, Ericka L. Fink, Peer Baneke, Anne Helme, Joanna Laurson-Doube, Marco T. Medina, Juan David Roa, Birgit Hogl, Allan O’Bryan, Claudia Trenkwalder, Jo Wilmshurst, Rufus O. Akinyemi, Joseph O. Yaria, David C. Good, Volker Hoemberg, Paul Boon, Samuel Wiebe, J. Helen Cross, Magali Haas, Inez Jabalpurwala, Marijeta Mojasevic, Monica DiLuca, Paola Barbarino, Stephanie Clarke, Sameer M. Zuberi, Paul Olowoyo, Ayomide Owolabi, Nelson Oyesiku, Pia C. Maly-Sundgren, Bo Norrving, Surjo R. Soekadar, Pieter A. van Doorn, Richard Lewis, Tom Solomon, Franco Servadei, and Neurology
- Subjects
Cellular and Molecular Neuroscience ,SDG 3 - Good Health and Well-being ,Neurology (clinical) ,610 Medicine & health - Abstract
The global burden of neurological disorders is substantial and increasing, especially in low-resource settings. The current increased global interest in brain health and its impact on population wellbeing and economic growth, highlighted in the World Health Organization’s new Intersectoral Global Action Plan on Epilepsy and other Neurological Disorders 2022–2031, presents an opportunity to rethink the delivery of neurological services. In this Perspective, we highlight the global burden of neurological disorders and propose pragmatic solutions to enhance neurological health, with an emphasis on building global synergies and fostering a ‘neurological revolution’ across four key pillars — surveillance, prevention, acute care and rehabilitation — termed the neurological quadrangle. Innovative strategies for achieving this transformation include the recognition and promotion of holistic, spiritual and planetary health. These strategies can be deployed through co-design and co-implementation to create equitable and inclusive access to services for the promotion, protection and recovery of neurological health in all human populations across the life course.
- Published
- 2023
3. Brain health conditions: Excellence in psychedelic treatments
- Author
-
Tadeusz Hawrot and David Badcock
- Abstract
Brain health conditions: Excellence in psychedelic treatments Psychedelic treatments open up an unparalleled window of opportunity, but we need to get ready for their roll-out. Mental healthcare is in crisis, and we don't have the tools to truly help millions of Europeans in need. In the EU, a shocking number of over 100 million people are affected by mental health conditions and alcohol use disorder and 56 000 die by suicide every year. And yet, few novel treatments have been developed by the pharmaceutical industry in the last several decades. We urgently need more innovation and psychedelic-assisted therapies (PATs) are emerging as a potent new class of novel treatments for mental, neurological and substance use disorders, as indicated by the rapidly growing, rigorous, and compelling body of research. In conjunction with proper psychosocial support, they hold the potential to provide safe, rapid-acting, and robust clinical improvements with durable effects.
- Published
- 2023
4. The neurology revolution
- Author
-
Mayowa O Owolabi, Matilde Leonardi, Claudio Bassetti, Joke Jaarsma, Tadeusz Hawrot, Akintomiwa I Makanjuola, Rajinder Kumar Dhamija, Wuwei Feng, Volker Straub, Jennifer Camaradou, David Dodick, Rosita Sunna, Bindu Menon, Claire Wright, Chris Lynch, Anna Dé, Coriene Catsman-Berrevoets, Muthoni Gichu, Cristina Tassorelli, David Oliver, Walter Paulus, K M Ramla, Augustina Charway-Felli, Kevin Rostasy, Valery Feigin, Audrey Craven, Elizabeth Cunningham, Orla Galvin, Ericka Fink, Peer Baneke, Marco T Medina, and Juan David Roa
- Subjects
Neurology ,Humans ,Neurology (clinical) - Published
- 2022
5. Health as a fundamental value. Towards an inclusive and equitable pharmaceutical strategy for the European Union
- Author
-
Éloïse Gennet, Aurélie Mahalatchimy, Markus Frischhut, Pin Lean Lau, Hervey, Tamara K., Flear, Mark L., Mary Guy, Inesa Fausch, Sabrina Röttger- Wirtz, Anne-Marie Duguet, Isabelle Moine-Dupuis, Tomislav Sokol, Mathieu Guerriaud, Joaquin Cayon- de las Cuevas, Elena Petelos, Marko Ocokoljic, Charlotte Godziewski, Olivier Negre, Piotr Kolczynski, François Houÿez, Hrishikesh Kulkarni, Marcin Rodzinka- Verhelle, Tadeusz Hawrot, Droits International, Comparé et Européen / Centre d'études et de recherches internationales et communautaires (CERIC) (DICE / CERIC), Droits International, Comparé et Européen (DICE), Aix Marseille Université (AMU)-Université de Pau et des Pays de l'Adour (UPPA)-Université de Toulon (UTLN)-Centre National de la Recherche Scientifique (CNRS)-Aix Marseille Université (AMU)-Université de Pau et des Pays de l'Adour (UPPA)-Université de Toulon (UTLN)-Centre National de la Recherche Scientifique (CNRS), Brunel University London [Uxbridge], University of London [London], Queen's University [Belfast] (QUB), Lancaster University, European Health Policy Platform of the European Commission, and ANR-20-CE26-0007,I-BioLex,Fragmentation et défragmentation du droit des innovations biomédicales(2020)
- Subjects
[SHS.DROIT]Humanities and Social Sciences/Law - Abstract
On behalf of the Interest Group on Supranational Biolaw of the European Association of Health Law (EAHL IG Biolaw) and the I-BioLex research project (ANR-20-CE26-0007-01), Éloïse Gennet and Aurélie Mahalatchimy have been coordinating, since September 2021, the thematic network on the pharmaceutical strategy on the European Health Policy Platform (EUHPP) of the European Commission. The thematic network of the EAHL IG Biolaw, selected by the European Commission and by the users of the EUHPP platform, is entitled “Health as a fundamental value. Towards an inclusive and equitable pharmaceutical strategy for the European Union”. This network enables to link the EAHL IG Biolaw, exclusively constituted by researchers and academics in the field of health law in Europe, on the one hand with the European Commission and in particular DG Health, and on the other hand with socio-economic actors interested in EU law applicable to medicinal products and medical devices (patient representatives, representatives of health professionals or non-governmental organizations in the field of health). After several months of fruitful exchanges, the final joint statement which was very favorably received by DG Health and endorsed by several organizations (including the President of Aix-Marseille University and the CNRS) has been presented at the EU Health Policy Platform Annual Meeting 2022 at the European Commission and published on the EUHPP in May 2022.
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.